Category Archives: HIV/TB Co-infection

PEPFAR adds to investment in rapid TB tests

By on .

The President’s Emergency Plan For AIDS Relief will buy as many as an additional 150 rapid tuberculosis testing devices with materials to test about 450,000 people for tuberculosis, addressing a need to improve diagnoses of drug-resistant strains of disease, and to identify the disease in HIV-positive people in sub Saharan Africa and Myanmar, the Office […]

Focus, inclusion, aspiration and language highlight changes in 2013 PEPFAR Country Operational Plan Guidance

By on .

What a difference a year can make, when sometime within that year a goal comes into focus. Every year the President’s Emergency Plan For AIDS Relief puts together a set of guidelines — a Guidance — on how to turn Country Operational Plans into the realities of setting, reaching and documenting goals to put epidemic-fighting […]

Lessons learned, lessons yet to be learned, Lancet’s MSM series, tuberculosis as kindling — HIV as the match, and more . . .

By on .

JAIDS all-PEPFAR supplement is free online and gives a past, present, future look at the President’s Emergency Plan For AIDS Relief as a historic effort that can still look forward to its greatest accomplishments. While the emphasis is on the program’s successes and a pre-AIDS 2012 panel discussion was light on the “lessons learned” from […]

Subsequent HPTN 052 data shows early HIV treatment is even more beneficial to patient, cost-effective

By on .

The good news keeps getting better for the HIV Prevention Trials Network (HPTN) 052 study, which found last year that HIV-infected persons on antiretroviral therapy (ART) were 96 percent less likely to transmit the virus to an uninfected partner through vaginal sex. At the International AIDS Conference (IAC) in Washington this week, two late-breaker sessions […]

PEPFAR recommends integrating international TB screening guidelines into prevention of mother to child HIV transmission work

By on .

Pointing to mounting evidence of the impact of tuberculosis on the health of pregnant women and their children, the President’s Emergency Plan For AIDS Relief is recommending improvements to efforts to detect the disease in settings offering health services to pregnant women, women with HIV, newborns, and children. “Recent studies have shown that HIV-infected pregnant […]

Analysis looks at fiscal savings, human toll

By on .

Unless Congress finds ways to lower the federal deficit by $1.2 trillion in the next five months,  the law passed last year mandating across-the-board cuts to nearly all budget items will reduce current global health spending by about 10 percent of its current level, an analysis by the Foundation for AIDS Research (amfAR) estimates. The […]

Global Fund countries respond to realities, make more of their money

By on .

Facing uncertain future funding, countries receiving grants from the Global Fund to Fight AIDS, Tuberculosis, and Malaria have used what they know about their own epidemics to redirect money to programs where it will have its greatest impact, the latest edition of Aidspan’s Global Fund Observer reports. The Fund has encouraged the effort during renewal […]

UN: World will fall short of ambitious 2015 HIV/AIDS goals

By on .

The United Nations (UN) General Assembly gave some bad news Monday – the 2015 global HIV/AIDS targets will not be met unless there is significant scale up in several areas. The targets were set by the 2011 Political Declaration on HIV and AIDS: Intensifying our Efforts to Eliminate HIV and AIDS. The declaration was adopted […]

Antiretroviral therapy as prevention: TB

By on .

Stephen Lawn reminded the audience at the International Treatment as Prevention Workshop in Vancouver on Wednesday that antiretroviral therapy (ART) goes a long way to protect HIV-infected individuals from tuberculosis (TB). The HIV-associated TB epidemic requires “radical interventions,” according to Lawn.  “DOTS [directly observed TB therapy, short course] just isn’t doing it.” He called the […]

Tackling TB/HIV co-infection in Africa: An interview with CDC’s Dr. Bess Miller

By on .

Science Speaks continues its interview series exploring the global HIV and tuberculosis research and development efforts at the U.S. Centers for Disease Control and Prevention (CDC) with a conversation with Bess Miller, MD, MSc, who works in the Division of Global HIV/AIDS. Dr. Miller has served as associate director and team lead for HIV/TB, providing leadership in policy and implementation of TB/HIV activities in 43 resource-limited countries supported by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). She has worked to align PEPFAR TB/HIV priorities with the World Health Organization (WHO) policies on TB/HIV, and on the use of antiretroviral therapy (ART) in people living with HIV (PLHIV). In this interview Dr. Miller discusses the successes and challenges in implementing TB infection control in Africa, progress in deploying the GeneXpert MTB/RIF rapid TB diagnostic on the ground there, and how efforts to scale up access to ART are helping achieve goals in TB control and elimination.